Articles producció científica> Medicina i Cirurgia

Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis

  • Datos identificativos

    Identificador: imarina:9335163
    Autores:
    Nomah, DKDíaz, YBruguera, AMoreno-Fornés, SAceiton, JReyes-Urueña, JLlibre, JMFalcó, VImaz, AFanjul, FJPeraire, JDeig, EDomingo, PInciarte, ACasabona, JMiró, JM
    Resumen:
    Background. Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minorities, including those with human immunodeficiency virus (HIV). Comprehensive studies are needed to understand the impact and risk factors.Methods. Using data from the PISCIS cohort of people with HIV (PWH) in Catalonia, Spain, we investigated COVID-19 outcomes and vaccination coverage. Among 10 640 PWH we compared migrants and non-migrants assessing rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, diagnosis, and associated clinical outcomes through propensity score matching and multivariable Cox regression.Results. The cohort (mean age, 43 years; 83.5% male) included 57.4% (3053) Latin American migrants. Migrants with HIV (MWH) had fewer SARS-CoV-2 tests (67.8% vs 72.1%, P < .0001) but similar COVID-19 diagnoses (29.2% vs 29.4%, P = .847) compared to Spanish natives. Migrants had lower complete vaccination (78.9% vs 85.1%, P < .0001) and booster doses (63.0% vs 65.5%, P = .027). COVID-19 hospitalizations (8.1% vs 5.1%, P < .0001) and intensive care unit (ICU) admissions (2.9% vs 1.2%, P < .0001) were higher among migrants, with similar hospitalization duration (5.5 vs 4.0 days, P = .098) and mortality (3 [0.2%] vs 6 [0.4%], P = .510). Age >= 40 years, CD4 counts <200 cells/mu L, >= 2 comorbidities, and incomplete/nonreception of the SARS-CoV-2 vaccine increased the risk of severe COVID-19 among migrants.Conclusions. MWH had lower rates of SARS-CoV-2 testing and vaccination coverage, although the rates of COVID-19 diagnosis were similar between migrants and non-migrants. Rates of COVID-19-associated hospitalizations and ICU admissions were higher among migrants in comparison with non-migrants, with similar hospitalization duration and mortali
  • Otros:

    Autor según el artículo: Nomah, DK; Díaz, Y; Bruguera, A; Moreno-Fornés, S; Aceiton, J; Reyes-Urueña, J; Llibre, JM; Falcó, V; Imaz, A; Fanjul, FJ; Peraire, J; Deig, E; Domingo, P; Inciarte, A; Casabona, J; Miró, JM
    Departamento: Medicina i Cirurgia
    Autor/es de la URV: Peraire Forner, José Joaquin
    Palabras clave: Vaccination Sars-cov-2 Migrants Hiv-infection Hiv Health Covid-19
    Resumen: Background. Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minorities, including those with human immunodeficiency virus (HIV). Comprehensive studies are needed to understand the impact and risk factors.Methods. Using data from the PISCIS cohort of people with HIV (PWH) in Catalonia, Spain, we investigated COVID-19 outcomes and vaccination coverage. Among 10 640 PWH we compared migrants and non-migrants assessing rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, diagnosis, and associated clinical outcomes through propensity score matching and multivariable Cox regression.Results. The cohort (mean age, 43 years; 83.5% male) included 57.4% (3053) Latin American migrants. Migrants with HIV (MWH) had fewer SARS-CoV-2 tests (67.8% vs 72.1%, P < .0001) but similar COVID-19 diagnoses (29.2% vs 29.4%, P = .847) compared to Spanish natives. Migrants had lower complete vaccination (78.9% vs 85.1%, P < .0001) and booster doses (63.0% vs 65.5%, P = .027). COVID-19 hospitalizations (8.1% vs 5.1%, P < .0001) and intensive care unit (ICU) admissions (2.9% vs 1.2%, P < .0001) were higher among migrants, with similar hospitalization duration (5.5 vs 4.0 days, P = .098) and mortality (3 [0.2%] vs 6 [0.4%], P = .510). Age >= 40 years, CD4 counts <200 cells/mu L, >= 2 comorbidities, and incomplete/nonreception of the SARS-CoV-2 vaccine increased the risk of severe COVID-19 among migrants.Conclusions. MWH had lower rates of SARS-CoV-2 testing and vaccination coverage, although the rates of COVID-19 diagnosis were similar between migrants and non-migrants. Rates of COVID-19-associated hospitalizations and ICU admissions were higher among migrants in comparison with non-migrants, with similar hospitalization duration and mortality. These findings can inform policies to address disparities in future pandemic responses for MWH.
    Áreas temáticas: Saúde coletiva Oncology Neurology (clinical) Microbiology Medicina ii Medicina i Infectious diseases Immunology Ciências biológicas i
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    Direcció de correo del autor: joaquim.peraire@urv.cat
    Identificador del autor: 0000-0001-7808-5479
    Fecha de alta del registro: 2024-08-03
    Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
    Enlace a la fuente original: https://academic.oup.com/ofid/article/11/1/ofad693/7511900?login=false
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Open Forum Infectious Diseases. 11 (1):
    Referencia de l'ítem segons les normes APA: Nomah, DK; Díaz, Y; Bruguera, A; Moreno-Fornés, S; Aceiton, J; Reyes-Urueña, J; Llibre, JM; Falcó, V; Imaz, A; Fanjul, FJ; Peraire, J; Deig, E; Doming (2024). Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis. Open Forum Infectious Diseases, 11(1), -. DOI: 10.1093/ofid/ofad693
    DOI del artículo: 10.1093/ofid/ofad693
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2024
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Immunology,Infectious Diseases,Microbiology,Neurology (Clinical),Oncology
    Vaccination
    Sars-cov-2
    Migrants
    Hiv-infection
    Hiv
    Health
    Covid-19
    Saúde coletiva
    Oncology
    Neurology (clinical)
    Microbiology
    Medicina ii
    Medicina i
    Infectious diseases
    Immunology
    Ciências biológicas i
  • Documentos:

  • Cerca a google

    Search to google scholar